WO2009025094A1 - Method of diagnosing cancer in mammal - Google Patents

Method of diagnosing cancer in mammal Download PDF

Info

Publication number
WO2009025094A1
WO2009025094A1 PCT/JP2008/050717 JP2008050717W WO2009025094A1 WO 2009025094 A1 WO2009025094 A1 WO 2009025094A1 JP 2008050717 W JP2008050717 W JP 2008050717W WO 2009025094 A1 WO2009025094 A1 WO 2009025094A1
Authority
WO
WIPO (PCT)
Prior art keywords
mammal
diagnosing cancer
midkine
optimizing
plasma
Prior art date
Application number
PCT/JP2008/050717
Other languages
French (fr)
Japanese (ja)
Inventor
Tsuneya Ohno
Original Assignee
Tsuneya Ohno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsuneya Ohno filed Critical Tsuneya Ohno
Priority to JP2009528961A priority Critical patent/JPWO2009025094A1/en
Publication of WO2009025094A1 publication Critical patent/WO2009025094A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

It is intended to provide a method of diagnosing cancer in a mammal. A method of measuring the concentration of midkine in the blood, in particular, in the plasma of a mammal carrying a malignant tumor by optimizing the combination of antibodies employed.
PCT/JP2008/050717 2007-08-20 2008-01-21 Method of diagnosing cancer in mammal WO2009025094A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009528961A JPWO2009025094A1 (en) 2007-08-20 2008-01-21 Method for diagnosing mammalian cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007213271 2007-08-20
JP2007-213271 2007-08-20

Publications (1)

Publication Number Publication Date
WO2009025094A1 true WO2009025094A1 (en) 2009-02-26

Family

ID=40378003

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/050717 WO2009025094A1 (en) 2007-08-20 2008-01-21 Method of diagnosing cancer in mammal

Country Status (2)

Country Link
JP (1) JPWO2009025094A1 (en)
WO (1) WO2009025094A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001020333A1 (en) * 1999-09-10 2001-03-22 Meiji Milk Prod Co Ltd Early cancer tumor marker

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001020333A1 (en) * 1999-09-10 2001-03-22 Meiji Milk Prod Co Ltd Early cancer tumor marker

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
AKIO HIRAMA ET AL.: "Saishin no chiryo guideline kankohensho", DOYAKUSHI, vol. 23, no. 5, 1 May 2006 (2006-05-01), pages 14 - 21 *
FU CHONG ET AL.: "Cloning and sequence of the xenopus laevis homologue of the midkine cDNA", GENE, vol. 146, no. 2, 2 September 1994 (1994-09-02), pages 311 - 312 *
MAMORU KONUMA: "Lymphoma no shindan to chiryo", VEC, vol. 4, no. 4, 1 December 2006 (2006-12-01), pages 18 - 36 *
MOTOJI KITAWAGA ET AL.: "Kensa data o kangaeru suigan", KENSA TO GIJUTSU, vol. 31, no. 1, 1 January 2003 (2003-01-01), pages 65 - 69 *
SATOSHI SAITO: "Kan saibogan no saihatsu to saihatsu yobo", THE JOURNAL OF MEDICINE, vol. 50, no. 1, 25 July 2003 (2003-07-25), pages 71 - 75 *
SHUNTARO IKEDA ET AL.: "Ushi midkine(MK) no cDNA cloning to ushi ranshi saiboshitsu seijuku sokushin inshi to shite no kumikae tanpakushitsu no sakusei", SHOKUNIKU NI KANSURU JOSEI KENKYU CHOSA SEIKA HOKOKUSHO, vol. 18, December 2000 (2000-12-01), pages 21 - 26 *
TAKEHITO YAMAGUCHI: "Suigan soki shindan no strategy suigan soki shindan no tame no shindan taikei no arikata", RINSHO SHOKAKI NAIKA, vol. 21, no. 13, 20 November 2006 (2006-11-20), pages 1717 - 1723 *
TSUJIMURA A. ET AL.: "Developmental and defferential regulations in gene expression of xenopus pleiotrophic factors-alpha and -beta", BIOCHEM.BIOPHYS.RES.COMMUN., vol. 214, no. 2, 14 September 1995 (1995-09-14), pages 432 - 439 *
YOSHINORI OISHI ET AL.: "Neko no kojosen gan no ichirei", THE JAPANESE SOCIETY OF SMALL ANIMAL VETERINARY MEDICINE SHOROKU, vol. 2004, 2004, pages 17 *
YOSHIYUKI KOBAYASHI ET AL.: "Kanzogan no rinsho kensa kanzogan shindan eno approach", CLINICAL TESTING, vol. 49, no. 11, 15 November 2005 (2005-11-15), pages 1201 - 1205 *

Also Published As

Publication number Publication date
JPWO2009025094A1 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
NZ598194A (en) Anti-cmet antibody and its use for the detection and the diagnosis of cancer
WO2007082144A3 (en) B7-h1 and survivin in cancer
WO2011143361A3 (en) Methods and compositions for diagnosing conditions
EP1922326A4 (en) Biomarkers useful for diagnosing prostate cancer, and methods thereof
WO2007109376A3 (en) Anti-tumor cell antigen antibody therapeutics
MX340453B (en) Biomarkers for lung cancer.
WO2010099342A3 (en) Methods of detecting lung cancer
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2010135692A3 (en) Mirna biomarkers of prostate disease
WO2008008284A3 (en) Cancer biomarkers and methods of use threof
WO2011045080A3 (en) Monoclonal antibodies to progastrin and their uses
MX2013000917A (en) Methods of detecting diseases or conditions using phagocytic cells.
NZ610592A (en) Anti-il-23 antibodies
WO2010009337A3 (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
WO2013066369A3 (en) Methods for detecting graft-versus-host disease
WO2010009171A3 (en) Src activation for determining cancer prognosis and as a target for cancer therapy
NZ616382A (en) Antibodies specific to cadherin-17
WO2011112845A3 (en) Methods and compositions related to a multi-methylation assay to predict patient outcome
WO2011074802A3 (en) Kit for diagnosing prostate cancer and diagnosis method
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
EP2275809A4 (en) Method of diagnosing pancreatic cancer with the use of n-binding type sugar chains
WO2012018877A9 (en) Treating breast cancer with anti-il-19 antibody
WO2009003082A3 (en) Immunological compositions as cancer biomarkers and/or therapeutics
WO2012059750A3 (en) Factors
WO2012145399A3 (en) Methods of diagnosing cancer in a patient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08703567

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009528961

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08703567

Country of ref document: EP

Kind code of ref document: A1